Demographic differences among patients treated with chimeric antigen receptor T‐cell therapy in the United States

Overview of attention for article published in Cancer Medicine, May 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news: 1 news outlet

twitter: 3 X users

Readers on

mendeley: 26 Mendeley

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 3,568 followers.

https://t.co/c39JSdC7tK

Demographic differences among patients treated with chimeric antigen receptor T-cell therapy in the United States #lymphoma #lymsm https://t.co/2rGi1CPrHx

New article: Demographic differences among patients treated with chimeric antigen receptor T-cell therapy in the United States https://t.co/FYq2CFHwuL #MMSM #MultipleMyeloma #hematology https://t.co/H2NHrqtK8T

Demographic differences among patients treated with chimeric antigen receptor T-cell therapy in the United States #lymphoma #lymsm https://t.co/0x3p3dOqEb

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.